Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 11,549,000 | 7,504,000 | 4,324,000 | 3,555,000 | 4,622,000 |
Depreciation Amortization | 8,521,000 | 6,542,000 | 4,415,000 | 2,215,000 | 6,471,000 |
Income taxes - deferred | -898,000 | -153,000 | -119,000 | -28,000 | -2,325,000 |
Accounts receivable | -1,321,000 | -572,000 | -1,162,000 | -866,000 | -929,000 |
Accounts payable and accrued liabilities | 1,719,000 | 1,454,000 | 308,000 | 236,000 | 1,514,000 |
Other Working Capital | -1,444,000 | -423,000 | -1,976,000 | -976,000 | 969,000 |
Other Operating Activity | 4,651,000 | 3,350,000 | 3,977,000 | 741,000 | 7,266,000 |
Operating Cash Flow | $22,777,000 | $17,702,000 | $9,767,000 | $4,877,000 | $17,588,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -787,000 | -600,000 | -383,000 | -188,000 | -798,000 |
Net Acquisitions | -1,902,000 | -837,000 | -345,000 | -198,000 | -39,610,000 |
Purchase Of Investment | -119,000 | -73,000 | -56,000 | -16,000 | -61,000 |
Sale Of Investment | 98,000 | 88,000 | 65,000 | 11,000 | 1,525,000 |
Other Investing Activity | 366,000 | 223,000 | 135,000 | 49,000 | 1,387,000 |
Investing Cash Flow | $-2,344,000 | $-1,199,000 | $-584,000 | $-342,000 | $-37,557,000 |
Cash Flows From Financing Activities | |||||
Debt Issued | 1,000,000 | 1,000,000 | 0 | 0 | 3,000,000 |
Debt Repayment | -9,414,000 | -5,662,000 | -3,461,000 | 0 | -5,683,000 |
Common Stock Issued | 244,000 | 169,000 | 144,000 | 71,000 | 209,000 |
Common Stock Repurchased | -934,000 | -803,000 | -797,000 | -787,000 | -978,000 |
Dividend Paid | -9,261,000 | -6,947,000 | -4,632,000 | -2,322,000 | -7,716,000 |
Other Financing Activity | -674,000 | -458,000 | -312,000 | -136,000 | -333,000 |
Financing Cash Flow | $-19,039,000 | $-12,701,000 | $-9,058,000 | $-3,174,000 | $-11,501,000 |
Exchange Rate Effect | -97,000 | -69,000 | -28,000 | -55,000 | -5,000 |
Beginning Cash Position | 8,449,000 | 8,449,000 | 8,449,000 | 8,449,000 | 39,924,000 |
End Cash Position | 9,746,000 | 12,182,000 | 8,546,000 | 9,755,000 | 8,449,000 |
Net Cash Flow | $1,297,000 | $3,733,000 | $97,000 | $1,306,000 | $-31,475,000 |
Free Cash Flow | |||||
Operating Cash Flow | 22,777,000 | 17,702,000 | 9,767,000 | 4,877,000 | 17,588,000 |
Capital Expenditure | -787,000 | -600,000 | -383,000 | -188,000 | -798,000 |
Free Cash Flow | 21,990,000 | 17,102,000 | 9,384,000 | 4,689,000 | 16,790,000 |